Use of beta-blockers has been a cornerstone in the treatment era following acute myocardial infarction (MI), especially in ...

China: A multicenter retrospective cohort study from China has identified frailty as a strong and independent predictor of ...

AliveCor announced today that it received FDA clearance for the next generation of its AI technology for the Kardia 12L ECG ...

Up to 189 health conditions could potentially affect your ability to drive, with seven specific conditions that must be ...

While AliveCore faced two wins, the dispute did not end there. In March 2025, Apple triumphed in a major patent dispute with ...

Currently available therapies such as niacin and PCSK9 inhibitors such as Repatha (evolocumab) and Praluent (alirocumab) can reduce Lp (a) levels, but their impact is modest. Another challenge in ...

The Department of Medical Service Administration under the Ministry of Health convened a meeting in Hanoi on January 10 to ...

The Ministry of Health on January 12 conducted a medical services drill at the National Convention Centre to ensure health ...

The annual report covers the five most impactful cardiovascular diseases, aiming for accountability and action.

The Department of Medical Service Administration under the Ministry of Health convened a meeting in Hanoi on January 10 to ...

Over 70 percent of patients in the first-line subgroup responded to amivantamab plus chemotherapy with most responses lasting beyond 16 monthsNotable ...

Detailed price information for Esperion Theraptc (ESPR-Q) from The Globe and Mail including charting and trades.